Marcellin 1991.
Methods | Allocation concealment: unclear. Blinding: no. Intention to treat: no. Methodological score: 12. | |
Participants | NAIVE PATIENTS WITH CHRONIC HEPATITIS C Arms: 18/18 Excluded: 2/0 Mean age: 42/41 % males: 67/50 % transfusion: 50/56 % drug abuse: 28/28 % cirrhosis: 17/11 Genotypes: NDA Disease duration: 4/4 | |
Interventions | Experimental: Alfa‐2b IFN 3 MU TIW x 6 mo Control: no intervention Follow‐up: 6 mo |
|
Outcomes | ‐ biochemical ETR and SR | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |